2010-2017年美国商业保险注射吸毒者HIV与HCV检测情况
本研究利用2010-2017年美国全国商业保险数据库,通过ICD、CPT和NDC编码识别注射吸毒者(PWID),评估其HIV和HCV检测率及影响因素。男性、农村居民及因皮肤感染或心内膜炎就诊者检测机会缺失风险更高。约90%的PWID错过了HIV或HCV检测机会。
要点
- 商业保险PWID中HIV和HCV检测率均不足10%。
- 男性、农村居民及皮肤感染/心内膜炎就诊者检测机会缺失风险更高。
- 约90%的PWID存在HIV或HCV检测机会缺失。
核心结论
- 约90%的推定PWID错过了HIV或HCV检测机会,尤其是男性农村居民及因皮肤感染或心内膜炎就诊者。
研究设计与样本
- 采用多因素logistic回归模型评估与检测相关的人口学和临床因素。
临床怎么用
- 对注射吸毒者,尤其男性、农村居民及因皮肤感染或心内膜炎就诊者,应主动提供HIV和HCV检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We assessed prevalence of testing for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection among persons who inject drugs (PWID). METHODS: Using a nationwide health insurance database for claims paid during 2010-2017, we identified PWID by using codes from the International Classification of Diseases, Current Procedural Terminology, and National Drug Codes directory. We then estimated the percentage of PWIDs tested for HIV or HCV within 1 year of an index encounter, and we used multivariate logistic regression models to assess demographic and clinical factors associated with testing. RESULTS: Of 844 242 PWIDs, 71 938 (8.5%) were tested for HIV and 65 188 (7.7%) were tested for HCV infections. Missed opportunities were independently associated with being male (odds ratios [ORs]: HIV, 0.50 [95% confidence interval {CI}, 0.49-0.50], P < .001; HCV, 0.66 [95% CI, 0.65-0.72], P < .001), rural residence (ORs: HIV, 0.67 [95% CI, 0.65-0.69], P < .001; HCV, 0.75 [95% CI, 0.73-0.77], P < .001), and receiving services for skin infections or endocarditis (adjusted ORs: HIV, 0.91 [95% CI, 0.87-0.95], P < .001; HCV, 0.90 [95% CI, 0.86-0.95], P < .001). CONCLUSIONS: Approximately 90% of presumed PWIDs missed opportunities for HIV or HCV testing, especially male rural residents with claims for skin infections or endocarditis, commonly associated with injection drug use.
引用
- Bull-Otterson L, Huang YA, Zhu W, et al. Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017. J Infect Dis. 2020. PMID: 32002537. doi:10.1093/infdis/jiaa017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。